Find news about our company, our business and product developments here.

Sirio Held Communication Meeting on Probiotic Gummies Innovation Technology and Probiotic Market Development

On December 17th and 19th, Sirio gathered academic experts, PhDs in R&D, and market insight experts in the field of probiotics in China and held respective communication meetings in Shanghai and Guangzhou on innovative technologies of probiotic gummies and the development of probiotic markets.

Sirio’s SAP ERP on-line to bolster IT strength

On December 2, Sirio Pharma formally launched the SAP ERP system that covers seven facets of its business operation, namely, finance, procurement, production, sales, warehouse management, customer service, and quality management.

Sirio Pharma and Kerry Group Form Ground-Breaking Agreement for Probiotic Gummies

Asia, Europe & The United States, 17 November, 2019: Sirio Pharma (300791) announces the signing of Probiotic Strategy Cooperation Agreement (BC30) with the Kerry Group. The collaboration was confirmed at Sirio’s China Research and Development Center in Shantou, Guangdong and is expected to harness the huge growth opportunity in China’s emerging probiotic gummy sector.

Sailing Together, in Pursuit of Health and Wellness SIRIO Inscribed in A-share Market

At the sound of the listing bell of the Shenzhen Stock Exchange on September 25, 2019, SIRIO Pharma Co. Ltd(share code: 300791)is officially listed on the A-share Market with an opening price of RMB 54.73 and closing price at RMB 76.60, an immediate increase of 39.96%.

SIRIO opens multimillion dollar gummy plant in Ma’anshan, China

Sirio Pharma Co. Ltd, the global nutraceutical contract development and manufacturing organisation (CDMO), announces the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan (300 km west of Shanghai, China).

Sirio Completes Acquisitions of well-known Soft Capsule Producer Ayanda

Sirio Pharma Co., Ltd (SIRIO) today announces that SIRIO has already completed acquisitions of Ayanda GmbH & Co. KG (Ayanda), a well-known softgel manufacturer in Europe. Ayanda has become a wholly-owned company of SIRIO.

Sirio Pharma sold Treerly to Pfizer

On January 13, 2016 Sirio Pharma sold its subsidiary company, Treerly Health Co., Ltd and its Treerly brand to Pfizer, the world’s largest pharmaceutical company.

Growing global market for long chain omega-3

An increasing foundation of positive clinical research coupled with regulatory recognition is driving consumer interest in long-chain omega-3 EFAs. This paper reviews the market drives and outlines potential areas for growth in the global arena.

Concentrated Fish Oil Softgel

Concentrated Fish Oil Softgel, containing fish oil and natural vitamin E as main ingredients is a dietary supplement. It is proven, by animal functional tests and human trials, to be efficacious in helping lower blood lipids.

DHA Algae Oil Vegetarian Softgel

Sirio’s DHA Algae Oil Vegetarian Softgel is the ideal product for both adults and children. Vegetarian DHA is essential for the development of eyes and brain. A single serving of DHA Algae Oil Vegetarian Softgel provides you with the daily amount of DHA (100mg), with no fishy smell or aftertaste.